- Home
- STRS vs VYGR Comparison
STRS vs VYGR Comparison
Compare STRS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- VYGR
- Stock Information
- Founded
- STRS 1992
- VYGR 2013
- Country
- STRS United States
- VYGR United States
- Employees
- STRS N/A
- VYGR N/A
- Industry
- STRS Homebuilding
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- STRS Real Estate
- VYGR Health Care
- Exchange
- STRS Nasdaq
- VYGR Nasdaq
- Market Cap
- STRS 155.7M
- VYGR 172.6M
- IPO Year
- STRS N/A
- VYGR 2015
- Fundamental
- Price
- STRS $17.94
- VYGR $3.24
- Analyst Decision
- STRS
- VYGR Strong Buy
- Analyst Count
- STRS 0
- VYGR 8
- Target Price
- STRS N/A
- VYGR $14.33
- AVG Volume (30 Days)
- STRS 21.9K
- VYGR 613.8K
- Earning Date
- STRS 08-12-2025
- VYGR 08-05-2025
- Dividend Yield
- STRS N/A
- VYGR N/A
- EPS Growth
- STRS N/A
- VYGR N/A
- EPS
- STRS N/A
- VYGR N/A
- Revenue
- STRS $32,719,000.00
- VYGR $66,958,000.00
- Revenue This Year
- STRS N/A
- VYGR N/A
- Revenue Next Year
- STRS N/A
- VYGR $78.88
- P/E Ratio
- STRS N/A
- VYGR N/A
- Revenue Growth
- STRS N/A
- VYGR N/A
- 52 Week Low
- STRS $15.10
- VYGR $2.65
- 52 Week High
- STRS $29.15
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- STRS 44.93
- VYGR 50.37
- Support Level
- STRS $17.89
- VYGR $3.15
- Resistance Level
- STRS $19.43
- VYGR $3.40
- Average True Range (ATR)
- STRS 0.84
- VYGR 0.19
- MACD
- STRS -0.14
- VYGR -0.00
- Stochastic Oscillator
- STRS 11.78
- VYGR 26.15
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.